ATE304548T1 - Antibakterielle verbindungen - Google Patents

Antibakterielle verbindungen

Info

Publication number
ATE304548T1
ATE304548T1 AT03004404T AT03004404T ATE304548T1 AT E304548 T1 ATE304548 T1 AT E304548T1 AT 03004404 T AT03004404 T AT 03004404T AT 03004404 T AT03004404 T AT 03004404T AT E304548 T1 ATE304548 T1 AT E304548T1
Authority
AT
Austria
Prior art keywords
compounds
antibacterial compounds
xvi
xiv
xiii
Prior art date
Application number
AT03004404T
Other languages
English (en)
Inventor
Inukai Masatoshi
Kaneko Masakatsu
Takatsu Toshio
Hotoda Hitoshi
Arai Masatoshi
Miyakoshi Shunichi
Kizuka Masaaki
Ogawa Yasumasa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of ATE304548T1 publication Critical patent/ATE304548T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/167—Heterorings having sulfur atoms as ring heteroatoms, e.g. vitamin B1, thiamine nucleus and open chain analogs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT03004404T 1998-07-09 1999-07-09 Antibakterielle verbindungen ATE304548T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19428598 1998-07-09
JP26944598 1998-09-24

Publications (1)

Publication Number Publication Date
ATE304548T1 true ATE304548T1 (de) 2005-09-15

Family

ID=26508414

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03004404T ATE304548T1 (de) 1998-07-09 1999-07-09 Antibakterielle verbindungen
AT99929772T ATE356825T1 (de) 1998-07-09 1999-07-09 Antibakterielle verbindungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT99929772T ATE356825T1 (de) 1998-07-09 1999-07-09 Antibakterielle verbindungen

Country Status (23)

Country Link
US (2) US6472384B1 (de)
EP (3) EP1319666B1 (de)
KR (2) KR100622889B1 (de)
CN (1) CN1181087C (de)
AT (2) ATE304548T1 (de)
AU (1) AU751470B2 (de)
BR (1) BR9911965A (de)
CA (1) CA2337225C (de)
DE (2) DE69927306T2 (de)
DK (2) DK1095947T3 (de)
ES (2) ES2248654T3 (de)
HK (2) HK1053063A1 (de)
HU (1) HUP0103711A3 (de)
ID (1) ID27955A (de)
IL (3) IL140731A0 (de)
NO (1) NO322083B1 (de)
NZ (1) NZ509233A (de)
PL (1) PL200426B1 (de)
PT (1) PT1095947E (de)
RU (1) RU2209210C2 (de)
TR (1) TR200100059T2 (de)
WO (1) WO2000002892A1 (de)
ZA (1) ZA200100200B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI245047B (en) * 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives
EP1322504A1 (de) 2000-09-25 2003-07-02 Volkswagen AG Airbagvorrichtung und betriebsverfahren dafür
US7652039B2 (en) * 2002-05-17 2010-01-26 Sequella, Inc. Methods of use and compositions for the diagnosis and treatment of infectious disease
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
EP1670314A4 (de) * 2003-09-05 2009-02-25 Sequella Inc Verfahren und zusammensetzungen enthaltend diamine als neue therapeutika für tuberkulose
CA2579756C (en) * 2004-06-19 2013-04-30 Human Biomolecular Research Institute Modulators of central nervous system neurotransmitters
US20090068325A1 (en) * 2007-09-10 2009-03-12 Gil Depicciotto Method of treatment of fresh produce
US20090281054A1 (en) * 2008-05-06 2009-11-12 Venkata Reddy Compositions and methods comprising capuramycin analogues

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60259190A (ja) * 1984-06-06 1985-12-21 Kanto Ishi Pharma Co Ltd 新抗生物質カプラマイシン及びその製造法
US5034381A (en) * 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
JPH05148293A (ja) * 1991-11-28 1993-06-15 Mect Corp 新規カプラマイシン誘導体およびその製造方法
GB9307043D0 (en) 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
TWI245047B (en) * 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives

Also Published As

Publication number Publication date
EP1319666B1 (de) 2005-09-14
DE69935513D1 (de) 2007-04-26
EP1319666A1 (de) 2003-06-18
CA2337225C (en) 2009-05-26
CN1181087C (zh) 2004-12-22
NO20010105L (no) 2001-03-08
PL200426B1 (pl) 2009-01-30
HK1053063A1 (en) 2003-10-10
HUP0103711A2 (hu) 2002-02-28
HUP0103711A3 (en) 2003-11-28
EP1319406A1 (de) 2003-06-18
NO20010105D0 (no) 2001-01-08
DE69927306T2 (de) 2006-07-06
IL140731A0 (en) 2002-02-10
ES2284260T3 (es) 2007-11-01
HK1053127B (en) 2005-12-30
NO322083B1 (no) 2006-08-14
US6844173B2 (en) 2005-01-18
NZ509233A (en) 2003-05-30
KR100729196B1 (ko) 2007-06-19
IL140731A (en) 2008-06-05
EP1095947B1 (de) 2007-03-14
ES2248654T3 (es) 2006-03-16
US6472384B1 (en) 2002-10-29
KR20010083101A (ko) 2001-08-31
KR100622889B1 (ko) 2006-09-12
BR9911965A (pt) 2001-05-29
WO2000002892A1 (fr) 2000-01-20
DK1095947T3 (da) 2007-07-16
IL187551A (en) 2009-12-24
ZA200100200B (en) 2002-06-26
ID27955A (id) 2001-05-03
KR20060011919A (ko) 2006-02-03
PT1095947E (pt) 2007-06-20
DE69927306D1 (de) 2005-10-20
IL187551A0 (en) 2008-03-20
EP1095947A1 (de) 2001-05-02
DK1319666T3 (da) 2005-12-05
RU2209210C2 (ru) 2003-07-27
CA2337225A1 (en) 2000-01-20
ATE356825T1 (de) 2007-04-15
EP1095947A4 (de) 2002-01-16
HK1053127A1 (en) 2003-10-10
AU4650599A (en) 2000-02-01
DE69935513T2 (de) 2007-11-29
CN1317008A (zh) 2001-10-10
TR200100059T2 (tr) 2001-05-21
PL345403A1 (en) 2001-12-17
AU751470B2 (en) 2002-08-15
US20030069204A1 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
IL187551A0 (en) Antimicrobial capuramycin derivatives and pharmaceutical compositions containing the same
GB9822450D0 (en) Medicaments
BR0014470A (pt) Inibidores de fab i
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
NZ506058A (en) Antibacterial 9-substituted tetracyclines, and pharmaceuticals and uses thereof
CY1106958T1 (el) Ν-αλκυλο-4-μεθυλεναμινο-3-υδροξυ-2-πυριδονες ως αντιμικροβιακα
NO951198D0 (no) Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene
ZA9710796B (en) Oxyiminopregnanecarbolactones.
GEP20094834B (en) Macrolides, pharmaceutical compositions containing them and their use for treatment of bacterial infections
ES2173391T3 (es) Derivados de 2-aminobenzazepina y su uso para el tratamiento de la inmunodepresion.
PT876388E (pt) Derivados de eritromicina triciclica
CY1108646T1 (el) Προβιοτικο βακτηριο γαλακτικου οξεος για την αντιμετωπιση βακτηριακων λοιμωξεων συνδεομενων με sids
GEP20084437B (en) Novel lincomycin derivatives possessing antimicrobial activity
MX9708611A (es) Compuestos de dialquiltiacumicina.
MD1788G2 (ro) Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
ES2115424T3 (es) Derivados prolin-amidicos basicos de los antibioticos ge 2270 y similares a ge 2270.
MY104109A (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
ATE250610T1 (de) Kaliumkanal-blockierende mittel
WO2000010998A3 (en) Pyridone antibiotic with improved safety profile
WO2002018353A3 (en) Oxazolidinone chemotherapeutic agents
FR2412564A1 (fr) Nouvelles 2' -n-acyl- et alkyl-6' -n-alkyl- et 6', 6' -di-n-alkyl-fortimicines a et b, utiles notamment comme antibiotiques
IL97040A0 (en) Novel antibiotic,deoxymulundocandin,a process for its production and its use as medicament
BR0312550A (pt) Derivados de nocatiacina o-derivatizados

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1319666

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee